KLF5 and prostate carcinoma: Additionally, phospholipase Cε, Kruppel-like factor 5 (KLF5), and protein kinase D3 can directly or indirectly interact with SREBP-1 to control lipid metabolism in the occurrence and progression of prostate cancer (75–77).